Horizon Therapeutics Public Limited Company Debt to Equity Ratio 2011-2023 | HZNP
Current and historical debt to equity ratio values for Horizon Therapeutics Public Limited Company (HZNP) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Horizon Therapeutics Public Limited Company debt/equity for the three months ending June 30, 2023 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-06-30 | $3.99B | $5.31B | 0.75 |
| 2023-03-31 | $3.90B | $5.10B | 0.77 |
| 2022-12-31 | $4.04B | $5.07B | 0.80 |
| 2022-09-30 | $3.99B | $5.03B | 0.79 |
| 2022-06-30 | $3.91B | $4.95B | 0.79 |
| 2022-03-31 | $3.92B | $4.82B | 0.81 |
| 2021-12-31 | $4.01B | $4.67B | 0.86 |
| 2021-09-30 | $4.16B | $4.45B | 0.93 |
| 2021-06-30 | $4.13B | $4.07B | 1.02 |
| 2021-03-31 | $3.99B | $3.86B | 1.04 |
| 2020-12-31 | $2.05B | $4.03B | 0.51 |
| 2020-09-30 | $1.97B | $3.80B | 0.52 |
| 2020-06-30 | $2.18B | $2.36B | 0.92 |
| 2020-03-31 | $2.13B | $2.19B | 0.97 |
| 2019-12-31 | $2.25B | $2.19B | 1.03 |
| 2019-09-30 | $2.17B | $1.56B | 1.39 |
| 2019-06-30 | $2.19B | $1.52B | 1.44 |
| 2019-03-31 | $2.43B | $1.50B | 1.62 |
| 2018-12-31 | $2.75B | $1.19B | 2.31 |
| 2018-09-30 | $3.10B | $0.92B | 3.38 |
| 2018-06-30 | $3.13B | $0.86B | 3.64 |
| 2018-03-31 | $3.14B | $0.86B | 3.65 |
| 2017-12-31 | $3.20B | $1.00B | 3.20 |
| 2017-09-30 | $3.17B | $1.00B | 3.17 |
| 2017-06-30 | $3.14B | $1.03B | 3.05 |
| 2017-03-31 | $3.17B | $1.21B | 2.63 |
| 2016-12-31 | $3.03B | $1.26B | 2.40 |
| 2016-09-30 | $1.99B | $1.36B | 1.46 |
| 2016-06-30 | $1.89B | $1.34B | 1.41 |
| 2016-03-31 | $1.91B | $1.29B | 1.48 |
| 2015-12-31 | $1.75B | $1.31B | 1.33 |
| 2015-09-30 | $1.74B | $1.26B | 1.38 |
| 2015-06-30 | $1.69B | $1.25B | 1.35 |
| 2015-03-31 | $0.84B | $0.69B | 1.22 |
| 2014-12-31 | $0.57B | $0.54B | 1.06 |
| 2014-09-30 | $0.64B | $0.49B | 1.32 |
| 2014-06-30 | $0.25B | $0.08B | 3.07 |
| 2014-03-31 | $0.53B | $-0.23B | -2.31 |
| 2013-12-31 | $0.30B | $-0.05B | -6.15 |
| 2013-09-30 | $0.09B | $0.07B | 1.26 |
| 2013-06-30 | $0.09B | $0.07B | 1.25 |
| 2013-03-31 | $0.09B | $0.08B | 1.02 |
| 2012-12-31 | $0.09B | $0.11B | 0.83 |
| 2012-09-30 | $0.08B | $0.13B | 0.65 |
| 2012-06-30 | $0.09B | $0.06B | 1.57 |
| 2012-03-31 | $0.09B | $0.08B | 1.07 |
| 2011-12-31 | $0.06B | $0.05B | 1.20 |
| 2011-09-30 | $0.06B | $0.13B | 0.50 |
| 2011-06-30 | $0.08B | $0.09B | 0.93 |
| 2011-03-31 | $0.00B | 0.00 | |
| 2010-09-30 | $0.00B | 0.00 | |
| 2010-06-30 | $0.00B | 0.00 | |
